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Multidisciplinary collaboration as a sustainable
research model for device development
Ankur Chandra, MD, Rochester, NY
The concurrent problems of research sustainability and decreased clinician involvement with medical device development
can be jointly addressed through a novel, multidisciplinary solution. The University of Rochester Cardiovascular Device
Design Program is a sustainable program inmedical device design supported through a collaboration between the Schools
of Medicine and Engineering. This article provides a detailed description of the motivation for starting the program, the
current structure of the program, the methods of financial sustainability, and the direct impact it intends to have on the
national vascular surgery community. The further expansion of this program and encouragement for development of
similar programs throughout the country aims to address many of our current challenges in both research funding and
device development education. (J Vasc Surg 2013;57:576-82.)
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cThe sustainability of medical research is of paramount
importance in the continued improvement of disease treat-
ment. Traditional methods of funding this research have
involved merit-based, extramural grants from national and
regional scientific organizations. Over the past decade and
anticipating the decade to come, funding amounts from
these organizations have been drastically cut to accommo-
date the coexisting economic climate. Because of this fact,
coupled with anticipated decreases in health care reim-
bursement, the outlook for the sustainability of the current
model of medical research is poor.
As medical devices continue to occupy an increasing
role in the interventional care of patients with cardiovascu-
lar disease, there is an equally increasing disconnect be-
tween the clinicians who use those devices and the engi-
neers who design them. Specifically, (1) biomedical
engineers lack a fundamental understanding of targeted
clinical needs and medical care delivery, and (2) clinicians
fail to address clinical needs with targeted device solutions
due to a lack of understanding of engineering capabilities
and approaches.1
Current industry-based cardiovascular device develop-
ment is an effective model for device approval and produc-
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576ion but does not effectively address clinical need-based
esearch and development (R&D). Most industry R&D
nvolves financial constraints often requiring limitations on
roject scope and focus. Furthermore, paradigm changing
&D for industry is revenue-negative and time-consuming.
his frequently results in R&D based on existing devices
510k) rather than clinical needs. The most effective
ethod of R&D is a direct translational process involving
linical needs identification with targeted device solutions.
he optimal approach to cardiovascular device develop-
ent in the future would involve the uncoupling of R&D
rom device approval and production, allowing R&D to be
erformed in the academic setting with device approval and
roduction accomplished through industry partnership
Fig 1). This model would allow both academia and indus-
ry to benefit from intellectual property and device sales,
espectively.
This article will outline in detail the specifics of the
niversity of Rochester Cardiovascular Device Design
CVDD) master’s degree, the involved parties and their
takes, and the methods for financial sustainability. The
irect benefits to the academic vascular surgery community
ill also be discussed. Through this program, we intend to
stablish a method of sustainable medical research for the
uture while re-establishing a clinician-engineer focus for
ovel device concepts.
ETAILS OF UNIVERSITY OF ROCHESTER
VDD MASTER’S DEGREE
ission statement
The mission of the program is to create innovative
evice solutions to focused clinical problems through a
ross-disciplinary collaboration. The program intends to
irectly affect improvement in patient care and outcomes
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Volume 57, Number 2 Chandra 577while promoting a unique education in both clinical car-
diovascular care and bioengineering design.
Program structure
The program is set up as a 1-year Master’s of Science
(MS) degree in biomedical engineering. Completion of the
MS degree requires a total of 30 credit hours over one full
calendar year (July-June; Table). The related coursework
covers topics involving clinical education, targeted engi-
neering principles, and technical entrepreneurship. The
program faculty includes both clinicians and engineers par-
ticipating at every level. The year is separated into two
Fig 1. Unique position of collaborative medical device design
program among the common interactions between clinical faculty,
engineering faculty, and the medical device industry. The device
design program can embody each of the existing interactions with
increased efficiency and productivity.
Table. University of Rochester Cardiovascular Device
Design Degree curriculum
Summer
● Summer in residence, 8-week clinical practicum
Fall semester (15 credits)
● Overview master’s course for biomedical engineering (4.0
credits)
● Graduate course relevant to clinical area of focus (3.0 credits)
● Ethics and professional integrity (1.0 credit)
● Course/seminar in medical device design and approval (4.0
credits)
● Device research and development (3.0 credits)
Spring semester (15 credits)
● Technical entrepreneurship (4.0 credits)
● Device research and development (3.0 credits)
● Choice of two biomedical engineering or approved engineer-
ing course relevant to project design (8.0 credits; 4.0 credits
each)
● Teaching assistant during the spring semester for biomedical
engineering senior design or other relevant course.segments, the clinical practicum and the design practicum. rClinical practicum. The clinical practicum begins July
and lasts for 8 weeks. The students are members of the
linical team 3 days per week from 7 am to 5 pm per day
Fig 2). This portion of the year represents one of the most
mportant and educational experiences for the design stu-
ent. The primary goals of these 2 months is to gain a
undamental understanding of the mechanisms of patient
are delivery, operating/procedure room technical capabil-
ties, and disease processes commonly treated in a cardio-
ascular care line. The students are also guided through
bservation and interview exercises to develop skills in
needs finding.” It is this exercise in ethnography that
llows the students to extract the necessary information
rom the surgeon, who is frequently not trained in engi-
eering principles. For this process to be successful, it
equires that the surgeons and clinical team conduct their
aily tasks without change so that the true clinical needs
ay be identified. Interactions with device representatives
nd outside research of current technology and scientific
iterature will further help students identify candidates for
rojects to receive further development.
Design practicum. The design practicum begins after
he 8-week clinical practicum and coincides with the begin-
ing of the academic year. The year is divided into quarters
uring which defined steps in the design process are assigned.
irst quarter
The first part of the design practicum involves a clinical
eeds identification meeting with the students and the
rogram faculty. At this meeting, students present a list of
linical needs identified, including a general description of
he clinical setting and problem as well as current alterna-
ives and their limitations. The subsequent project proposal
rocess requires the students to synthesize their clinical expe-
iences and needs analysis toward a focused solution. Initially,
wo or more full-length project proposals are discussed at the
roject vetting meeting. This meeting includes all program
aculty, resulting in amultidisciplinary analysis of each idea and
ig 2. Participation in a clinical practicum has allowed the engi-
eering students to obtain a robust understanding of clinical care
elivery while assisting the clinicians regarding technical aspects of
evice development.ecommendations on which project goes into further devel-
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February 2013578 Chandraopment for each student. It is at this point that intellectual
property (IP) disclosures in conjunction with the Office of
TechnologyTransfermay commence for certain projects. The
IP rights under the CVDDprogram are owned by the univer-
sity and assigned to the named inventors (students and specific
mentors) with any related revenue distributed to both named
inventors as well as their respective departments and schools
on a graded scale based on overall amount.
Second and third quarter
This second and third quarter of the year is when the
students’ engineering principles merge with their clinical
needs assessment. A systematic approach is used to clearly
articulate the design specifications, generate solutions, and
refine the selected concept for prototyping. During this time,
the student is expected to function as a project team leader
with clinical research residents available to participate in the
project team. The student is responsible for a project timeline,
concrete deliverables every 2 weeks, and identifying R&D
needs. Meetings with faculty take place at 2-week intervals to
discuss the progress of the project, including scheduled deliv-
erables, obstacles, and needs. Detailed drawings, analysis, and
othermaterials supporting the design concept are presented in
both written and oral form to a panel of engineers and clini-
cians. Presentation might include demonstration of an early-
stage prototype as well as plans for further prototyping.
Students then develop proof-of-concept prototypes us-
ing an iterative approach to demonstrate key feasibility of
their selected concept. Managing their own prototyping
budget, students coordinate manufacturing of one or more
prototypes to demonstrate their concept and identify key
issues for testing. Students periodically meet with program
faculty to report on progress, demonstrate prototype, and
establish a plan for testing.
Fourth quarter
This part of the year represents the practical testing of
the project as a preparation for obtaining IP rights. In
conjunction with the office of technology transfer, the
student assesses the deficiencies of the designed project in
regard to clinical acceptance or the marketing of licensing
rights. A series of targeted experimental trials using avail-
able resources at the university allows the student to obtain
preliminary data necessary to differentiate his or her project
from similarly existing patents. The data acquired should be
directly applicable to the primary claims section of the
patent application. The planning and execution of this
testing requires close collaboration with not only the clin-
ical and engineering advisers but also with the office of
technology and their assessment of competing/existing
patents. The MS exit examination consists of submission
and oral defense of a written report of the design solution
and proposed implementation for further development.
This may include a demonstration of the prototype, report-
ing on test results for critical design concepts, a draft of
claims for a patent application, description of regulatory
hurdles, identification of the pathway toward clinical eval-
uation, and critical elements of a business plan.ROGRAM PARTICIPANTS AND STAKES
The overall framework of the program is an MS in an
pplied science discipline with a focus of work in a defined
linical field. The program itself is composed of and sup-
orted by several people, including the students of the
rogram, the clinical faculty, the engineering faculty, the
niversity leadership (chairs and deans), and industry. Out-
ined below is a summary of the role of each group and their
ontributions/returns of participation.
ascular surgery faculty
One member of the faculty must serve as the clinical
irector to oversee the clinical activities. The faculty group
s a whole is responsible for teaching and providing guid-
nce to the clinical delivery of care and the corresponding
eeds associated with deficiencies of that process. This
roup holds a unique role as the only people who actually
eliver the device into patients. It is critical that senior
aculty participate to provide their unique insight related to
hese devices. The ability and willingness of these individ-
als to participate is directly related to the academic and IP
eturns they can expect from their participation with little
xtra time required from their existing daily schedules.
Contributions.
● Clinical experience and education;
● Novel and unique insight into delivery and use of
devices;
● Time separate from other clinical activities.
Returns.
● Academic credentials and publications related to de-
sign process;
● Structured framework to develop device concepts and
IP generation.
ngineering faculty
One member of the faculty must serve as the engineer-
ng/academic director to oversee both the design process
nd the educational component of themaster’s degree. The
aculty group as a whole is responsible for teaching and
roviding guidance to the engineering principles related to
eveloped device concepts. This may involve faculty from
ultiple engineering disciplines based on project needs.
Contributions.
● Formal design process education appropriate for a
master’s-level degree;
● Specialized engineering expertise related to needs of
the specific projects;
● Structural/laboratory resources to facilitate device de-
velopment (wet laboratory, machine shop, prototype
production).
Returns.
● Reliable clinical collaborations and formal relationship
with medical center faculty;
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Volume 57, Number 2 Chandra 579● Opportunity to develop device concepts related to
their existing research interests;
● Increase in volume of graduate students for depart-
ment;
● Ability to function as “consultants” for projects that
may result in IP generation.
Students of the program
The primary role of the student is to learn and become
an expert in the process of device design from clinical needs
identification through prototype/feasibility testing. These
individuals will obtain a multidisciplinary education not
traditionally available through currently existing engineer-
ing or medical models.
Contributions.
● Intellectual investment and time toward project devel-
opment;
● Commitment to learn relevant aspects of clinical envi-
ronment and needs.
Returns.
● Highly specialized education in unique multidisciplinary
field from experts in those fields;
● Opportunities for postgraduate employment through in-
dustry partners.
University, Department Chairs, and Deans
These entities and individuals provide the structure and
framework for the program to exist. The university role
includes IP/technology transfer resources to offset the cost
of concept translation to patent. IP at the University of
Rochester and the CVDD is assigned to the named inven-
tors as well as their respective departments and schools. The
roles of the departments are to provide the ability to confer
an academic degree while the school deans provide the
overall vision for the program in the context of the needs of
the schools and university environment.
Contributions.
● Degree-granting infrastructure;
● Academic reputation to attract students;
● Support for program faculty;
● IP/technology transfer experts available to program
faculty and students.
Returns.
● Academic reputation for unique educational program;
● Tuition revenue for program support and resource
development;
● Directed, need-based IP generation, which will translate
into increased licensing of patent rights to industry.
Industry
The role of industry is to provide both guidance during
the design process as well as being a partner to continue the
device lifecycle after R&D through the program is com-
plete. Industry participation in the program is critical as, in
most cases, the university framework does not represent the mptimal setting for marketing, clinical trials, and device
roduction.
Contributions.
● Financial support through grant funding;
● Oversight and guidance in the design process regard-
ing feasibility and market conditions;
● Infrastructure to license IP rights of devices produced
and translate them into Food and Drug Administration-
approved implants.
Returns.
● Opportunity to employ highly trained program grad-
uates able to immediately contribute, rather than hav-
ing to provide untrained engineers on-the-job train-
ing;
● Ability to obtain first-right-of-refusal agreements for
licensing of developed IP;
● Unique method of establishing university/academic
affiliation as platform for other collaborations.
ETHODS OF PROGRAM SUSTAINABILITY
One of the most important aspects of any successful
esearch program is financial sustainability. While extramu-
al funding remains a vital driver of this process, it is
mportant to identify that the collaborative environment of
n academic medical center and affiliated university possess
esources that can be more efficiently used to provide this
ustainability. Below is a description of the potential for
ncome and expenses to support this type of program
ndependently.
Income/revenue. The three primary sources of reve-
ue for the CVDD program are tuition, industry partner-
hip support, and grants. In a practical sense, the largest and
ost important of these is tuition. The ability to collect
uition is directly related to establishing a program that is
ttractive to students and can provide them with training
equired to be competitive for employment opportunities.
he unique combination of a clinical and engineering
ducation targeted toward directly employable graduates is
successful model in attracting students and tuition. For an
stimated 10 students per year at $15,000 tuition per
tudent, this provides a yearly revenue of $150,000. Finan-
ial support from industry is directly related to providing
he industry partner a product both cheaper and more
fficiently than they can produce themselves. The success of
he CVDD program is in the ability to provide companies
ith highly trained graduate-level engineers who already
ave a facile knowledge of the clinical arena and the trans-
ation of clinical needs to device solutions. Most companies
pend considerable money training entry-level engineers to
level required to be a functional member of a design team.
ur model for industry partnership has been yearly support
f $10,000 to $30,000 per company in exchange for first
ight of recruitment for the graduating students. With two
ompany partners per year, this, conservatively, provides a
early revenue of $20,000 to $30,000. In our current
odel, any revenue generated from grant funding is a
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February 2013580 Chandrabonus. Furthermore, through directed use of the recurring
revenue streams above, the ability to obtain grant funding
with preliminary projects and products is accentuated. In a
conservative estimate, the program’s yearly revenue is
$180,000.
Expenses. As in many research programs, the primary
budgetary considerations for the CVDD program are hu-
man resources, material resources, administrative infra-
structure, and space. Capitalizing on the existing university
resources, the costs for human resources in terms of clinical
and engineering faculty are met both in financial compen-
sation and academic opportunities. The program directors
can be provided financial compensation mainly to offset
many of their administrative commitments as well as their
continued time commitment throughout the academic
year. This amount is proposed to be $30,000 per year. For
the participating faculty, no direct compensation is pro-
posed, but several unique academic opportunities are pro-
vided. These include participating in project development
related to their research and/or academic interests with
dedicated full-time equivalent in the form of graduate
students. This also provides many clinical faculty a means to
pursue device development with an engineering team and
the resources of the university technology transfer/IP of-
fice. The administrative infrastructure of the academic de-
gree component is handled by the existing offices in the
department of biomedical engineering and, as such, re-
Fig 3. The self-sustaining cycle of a collaborative design
of development continues to build upon the prior, resulti
a strong university brand reputation.quires minimal additional monetary resources. The sched- sle for the clinical rotations and student hospital orienta-
ion is organized in parallel with clinical trainee scheduling
nd likewise requires minimal funding. The yearly amount
o fund administration is proposed to be $10,000. The
emainder of the yearly budget is applied to both material
esources and space to mutually benefit both the clinical
nd engineering groups. A defined academic space and
aboratory space for the students is necessary. The creation
f novel core facilities such as design and fabrication shops,
nimal facilities for prototyping and testing, and computing
ores for simulation and computer-aided design models are
ossible. A yearly expense of $50,000 for academic and
aboratory space at both the medical center and the engi-
eering school is proposed. This allows for a discretionary
ortion of the remaining $90,000 budget to be applied
oward design equipment, computing resources, and devel-
ping design facilities. Any grant funding obtained can
hen be applied to expanding the scope of the program to
llow for larger student capacity. These estimates are based
n the premise that redirected use of all funds should lead
o a self-sustaining cycle of program expansion, increased
uition revenue, increased industry partnerships, and more
obust university facilities (Fig 3).
ENEFITS TO THE ACADEMIC VASCULAR
URGERY COMMUNITY
There are several direct benefits to the field of vascular
ram. Once the program has been established, each phase
a sustainable research program with robust facilities andprog
ng inurgery for participation and leadership in this device de-
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Volume 57, Number 2 Chandra 581sign collaboration. Specifically, we are able to participate in
and understand the device development process, as well as
begin to better train vascular surgeons in the technical
aspects of the devices we use.
As the device industry grows, there is a glaring discon-
nect between the vascular surgeon’s understanding of the
technical aspects of using a device and his or her under-
standing of the process involved in creating that device. In
order to use current devices appropriately, surgeons must
have a deeper understanding of the tolerances and capabil-
ities of those devices. This has recently contributed to many
issues related to “off-label” use of devices with undesired
outcomes.2 An Indy car driver actively participates in the
design of his or her car to maximize speed and safety on the
course; surgeons should be expected to do the same. While
most surgeons have some interest in but little extra time to
learn the design process, involvement in the CVDD collab-
oration allows them this opportunity. There is no require-
ment for surgeons to have any background in engineering.
The students of the program are trained by the engineering
faculty in interview and ethnographic tools that will provide
them the skills to extract the necessary information from
the clinical arena. While the concern of surgical faculty
having little to no background in device design has arisen, it
is the insight into the indications, use, delivery, and out-
comes of devices that encompasses the surgeons’ chief
contribution.
The vascular surgery community must have a credible
voice in industry device development and participation in
this process is the first step. Currently, many surgeons
participate in device design as consultants to industry
groups with payment in return for clinical and device
insight. It is critical to mention that this is an important
practice that could allow these individuals with existing
experience to actively participate as mentors or leaders for
this type of training.
The training of future vascular surgeons in concepts
related to device engineering and design will allow them a
unique research experience while positioning our field to be
national leaders in this area in the future. The unique
feature of the CVDD program is the participation of vas-
cular surgery residents and fellows as “clinical consultants”
for the design students. In an era where funding dedicated
research time for clinical trainees is increasingly difficult,
their role as consultant is possible during clinical rotations
and has been very attractive to them as a potential part of
their training. For many, this may allow for research pro-
ductivity sufficient to pursue an academic career without
arranging for dedicated “lab years.” Undoubtedly, this
experience has given them insight not otherwise possible
into engineering concepts behind devices, as well as a
formal education in the device approval process.
SIMILAR EXISTING DEVICE DESIGN
PROGRAMS AND THEIR RELEVANCE TO
CVDD
Several other universities have pursued similar paths in
creating specialized, multidisciplinary areas of study in de- cice or medical technology innovation. These programs
ave all been established over the past 5 to 10 years with
lightly differing curriculum, structure, or mission. It is
mportant to emphasize that the CVDD was conceived,
stablished, and supported by an academic division of vas-
ular surgery and department of biomedical engineering in
he absence of a significant institutional commitment.
The Biodesign Program at Stanford has been in exist-
nce the longest and has, by far, the largest variety of fields
f medical and applied science to which it serves. The key
ttributes of the Stanford program are that they recruit all
tudents (undergraduate, graduate, doctoral candidates,
nd postdocs) and involve all specialties in engineering and
ife sciences.While this model clearly “casts the widest net,”
t also demands a large and more complex infrastructure.
urthermore, the Biodesign program involves the business
chool and marketing as parts of the experience. Our pro-
ram has not included these, as we have designed the
rogram to consider several of these issues. The nature of
he CVDD design process, which starts with the properly
etted clinical need and involves surgeon/engineer part-
ership for development, inherently involves market anal-
sis, clinician utility, and efficacy.
Johns Hopkins University currently runs the Center of
ioengineering and Innovation Design as well as the David
. Swirnow Master’s of Science in Bioengineering and
nnovation and Design. This 1-year program includes ed-
cation on clinical, technical, and business aspects of health
are innovation. This program also includes an 8-week
linical immersion experience for the design student, which
ncludes multiple areas of medicine, including Cardiology,
rthopedic Surgery, General Surgery, Gastroenterology,
bstetrics/Gynecology, Neurosurgery, Ophthalmology,
rology, and Interventional Radiology.
The University of Cincinnati offers an undergraduate
rogram in device design called the Medical Device Inno-
ation and Entrepreneurship Program. The strength of this
rogram is its unique curriculum approach to device design
hrough courses to expose the students to many practical
spects of devices such as “Device Reverse Engineering,”
here students take existing devices and disassemble them
o gain insight into their structure/function relationship.
he students participate in this experience as part of their
apstone senior design requirements. This center has no
raduate programs, however. The involvement of graduate
tudents who can focus on single projects as their year of
tudy is critical, as undergraduates often have many de-
ands on their time and varying degrees of commitment.
his mainly impacts the depth and complexity of projects
ompleted and would clearly benefit from an additional
raduate program.
The University of California, San Diego, Jacobs School
f Engineering has announced a Master’s of Advanced
tudy Degree in Medical Device Engineering. This is a
-year master’s program, which we have found will impact
he number of interested students. The program is under
ontinuing development and currently involves some
linical exposure. The biggest challenge for this and
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February 2013582 Chandramany of the programs mentioned is how to involve
engineering students in an already busy clinical teaching
environment. Our proposed solution is the previously
described integration of these students in the clinical set-
ting but with distinctly different tasks that require observa-
tion and directed questioning not related to traditional
disease process education.
There are several other programs that focus on the
process of device development with varying involvement of
academicmedical centers and clinical rotations.While com-
plete description of all of these programs is beyond the
scope of this review, it is important to note the widespread
interest in multidisciplinary research to further study in
multiple clinical and applied science areas.
CURRENT RESULTS OF PILOT YEAR AND
BENEFITS TO ENGINEERING DEPARTMENT
The first year of the CVDDprogram has resulted in two
robust projects by the two initial students. Both projects
have resulted in IP disclosures to the university with provi-
sional patents involving the student, engineering faculty,
and clinical faculty as named inventors. Both engineering
graduate students are well versed in all technical aspects of
cardiovascular device use and implementation with an ex-
tensive clinical knowledge base. One of the students is
entering a PhD program in biomedical engineering with a
focus on cardiovascular disease, and the other has offers to
enter industry. The program has resulted in an increase in
master’s applications for the department of biomedical
engineering. Plans for the upcoming year include incorpo-
ration of clinical trainees into the design teams as well as
exploring extension of the program through partnerships
with other regional engineering departments. In many
ways, this program has clearly appealed to those graduates
who desire a unique multidisciplinary education, making
them more immediately employable upon graduation. The
key program metrics going forward will be the number of
IP disclosures per year, the number of students applying to
the program, and the number of graduates who gain em-
ployment in industry as R&D engineers.
CONCLUSIONS
The University of Rochester CVDD Master’s Degree
Program intends to generate a new paradigm of device Sevelopment in an era of increasing health care cost con-
traints and limited commercial resources. The graduates
nd associated intellectual property of this program will
irectly improve patient care through increased efficiency
f clinician-engineer communications, more targeted and
ffective devices, and shifting device R&D from profit-
ased to need-based development.
Through the use of existing resources at a university-
ased, academic medical center, a sustainable solution to
romote continued progress in disruptive technology de-
elopment has been created. This program embodies the
ollowing aims:
. Provide engineering graduate students a detailed edu-
cation in cardiovascular clinical care and needs finding
through a structured clinical immersion practicum
. Provide clinicians the opportunity to partner with de-
sign students to R&D-targeted device solutions to iden-
tified clinical needs
. Create a master’s degree with supplemental coursework
to produce a new generation of engineers with unique
multidisciplinary skills
. Generate novel intellectual property for industry part-
nership toward more effective device applications
This program provides a critical framework to facilitate
ross-disciplinary collaborations toward practical applica-
ions. The mutual exchange of resources between academic
nd clinical departments can be directed toward growing
his research program for mutual benefit. The role of aca-
emic institutions in redirecting medical device develop-
ent is crucial in continuing paradigm-changing device
rogress. This area of work represents an opportunity all
niversity/academic medical centers should be encouraged
o undertake.
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